Li Y, Sun L, Burstein DS, Getz KD
Considerations of Competing Risks Analysis in Cardio-Oncology Studies: JACC: CardioOncology State-of-the-Art Review
J Am Coll Cardiol CardioOnc 2022;4(3):287-301
In the Central Illustration, the text in Q1 was “Occurrence of Z (primary event of interest) precludes observation of Y (secondary event that is a potential competing risk)” but should have been “Occurrence of Z (secondary event that is a potential competing risk) precludes observation of Y (primary event of interest)”.
Central Illustration.
Framework for Assessing Competing Risk Conceptually
Here Y represents the primary event of interest, and Z represents the secondary event that is potentially a competing risk for Y. Examples A (classic competing risk), B (composite outcome), and C (dependent censoring) are further explained in the text (in the section “Competing Risks Overview”), and examples D (intermediate event) and E (loss to follow-up) are explained in the Supplemental Appendix. Q1 = Question 1; Q2 = Question 2; Q3 = Question 3; Q4 = Question 4; Q5 = Question 5; Q6 = Question 6.
The authors apologize for this error. The current online version has been corrected.

